Delivery Order SPE2DB22D1017-SPE2DB24FE7CQ
Award Date 10/12/23
Potential Completion Date 10/13/23
Potential Value $1.2K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Defense Logistics Agency awarded a $2,343.24 firm fixed-price delivery order to Amerisourcebergen Drug Corp on October 11, 2023 for CREON DR 36,000 unit capsules. Performance will take place in Conshohocken, Pennsylvania, with an estimated completion date of October 12, 2023. The delivery order was issued under an existing Amerisourcebergen Corporation vehicle and has no set-aside designation. As a healthcare supplier to the DLA, Amerisourcebergen will fulfill this order for pancreatic enzyme...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred ninety-five dollars and twenty-seven cents to Amerisourcebergen Drug Corporation for 4561947397 CREON DR 36,000 unit capsules. The order is to be performed in Conshohocken, Pennsylvania by August 28, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order for pancreatic enzyme replacement therapy capsules to support the Defense...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred ninety-five dollars and twenty-seven cents to Amerisourcebergen Drug Corporation for 4561730930 CREON DR 36,000 unit capsules. The order is to be performed in Conshohocken, Pennsylvania by August 8, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill the order for pancreatic enzyme replacement therapy capsules to support the Defense...
- The Defense Logistics Agency awarded a $195,270 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561837122 CREON DR 36,000 unit capsules. The single day order is to be fulfilled on August 16th through 17th 2023, with performance taking place in Conshohocken, Pennsylvania. As a top pharmaceutical supplier, Amerisourcebergen will deliver the pancreatic enzyme replacement therapy capsules in support of the Defense Logistics Agency's medical supply needs. No...
- The Defense Logistics Agency awarded a $195.27 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562225320 CREON DR 36,000 unit capsules. As the prime contractor, Amerisourcebergen will deliver the pancreatic enzyme replacement therapy medication to a facility in Conshohocken, Pennsylvania, under a single day performance period from September 19th through September 20th, 2023. The parent company, Amerisourcebergen Corporation, will perform through its corporate office...
- The Defense Logistics Agency awarded a $14,612.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s. The contract, with an ultimate completion date of November 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was not designated as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy) in 100-count packaging, valued at $2,254.12. This is a firm fixed-price delivery order with no set-aside designation, issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $478.94 to Amerisourcebergen Drug Corporation for 4562160389 CREON DR 36,000 unit capsules. As the prime contractor, Amerisourcebergen will deliver the pancreatic enzyme replacement therapy capsules to a location in Conshohocken, Pennsylvania by September 14, 2023 to support the Department of Defense's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules, valued at $5,684.41. This firm fixed-price delivery order, issued on August 22, 2025, represents a non-competitive, non-set-aside award with an ultimate completion date of August 25, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed...
- The Defense Logistics Agency awarded a $585 delivery order to Amerisourcebergen Drug Corporation for 36,000 unit capsules of CREON DR. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pancreatic enzyme replacement therapy medication to a facility in Conshohocken, Pennsylvania under a firm fixed price contract. The parent company, Amerisourcebergen Corporation, will perform through its corporate office and division. This delivery order was issued against an existing...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FE7CQDelivery Order
Defense Logistics Agency awarded a $1,171.68 firm fixed price delivery order to Amerisourcebergen Drug Corp on October 12, 2023 for CREON DR 36,000 unit capsules. Performance will take place in Conshohocken, Pennsylvania, with no set-aside designation specified. As the parent company, Amerisourcebergen Corporation will support fulfillment of the order through their Corporate Office and branded as Amerisourcebergen. This delivery order was issued against an existing DLA vehicle to supply pancreatic enzyme replacement therapy medications in support of the agency's medical logistics programs.
Generated 1/11/24, 9:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/12/23 |